Total Payments
$723.87
2024 Payments
$52.96
Companies
13
Transactions
24
Medicare Patients
7,610
Medicare Billing
$301,448
Payment Breakdown by Category
Food & Beverage$723.87 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $723.87 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $124.35 | 2 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $122.92 | 2 | $0 (2017) |
| Jazz Pharmaceuticals Inc. | $102.69 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $65.44 | 5 | $0 (2024) |
| Gilead Sciences, Inc. | $61.64 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $60.22 | 4 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $50.00 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $37.69 | 2 | $0 (2023) |
| Novo Nordisk Inc | $23.83 | 1 | $0 (2017) |
| Xeris Pharmaceuticals, Inc. | $23.74 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52.96 | 3 | GlaxoSmithKline, LLC. ($29.22) |
| 2023 | $37.69 | 2 | Novartis Pharmaceuticals Corporation ($37.69) |
| 2021 | $16.82 | 1 | Amarin Pharma Inc. ($16.82) |
| 2020 | $12.15 | 1 | GlaxoSmithKline, LLC. ($12.15) |
| 2019 | $32.80 | 2 | Janssen Pharmaceuticals, Inc ($32.80) |
| 2018 | $210.04 | 5 | Shire North American Group Inc ($124.35) |
| 2017 | $361.41 | 10 | SANOFI-AVENTIS U.S. LLC ($122.92) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX, ROTARIX | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: VACCINES | ||||||
| 01/24/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/09/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/04/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Cardiovascular | ||||||
| 12/17/2020 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: VACCINES | ||||||
| 10/01/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/15/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/13/2018 | Shire North American Group Inc | ELAPRASE (Biological) | Food and Beverage | In-kind items and services | $110.52 | General |
| Category: GENETIC DISEASE | ||||||
| 09/19/2018 | Shire North American Group Inc | VPRIV (Biological) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: GENETIC DISEASE | ||||||
| 07/11/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/13/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $61.64 | General |
| 06/12/2018 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: VACCINES | ||||||
| 11/29/2017 | GlaxoSmithKline, LLC. | BEXSERO (Biological), BOOSTRIX, FLUARIX | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: VACCINES | ||||||
| 10/12/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $105.25 | General |
| Category: DIABETES | ||||||
| 09/21/2017 | Novo Nordisk Inc | Victoza (Drug), Xultophy 100/3.6, Tresiba | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Diabetes | ||||||
| 08/01/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: DIABETES | ||||||
| 05/17/2017 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), BELSOMRA, DULERA | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: RESPIRATORY | ||||||
| 04/19/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/12/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/11/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: Cardiovascular | ||||||
| 02/17/2017 | Jazz Pharmaceuticals Inc. | Xyrem (Drug) | Food and Beverage | In-kind items and services | $102.69 | General |
| Category: Neurology | ||||||
| 01/24/2017 | PFIZER INC. | LYRICA (Drug), VIAGRA | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 11 | 664 | 797 | $157,472 | $32,836 |
| 2021 | 21 | 5,444 | 6,100 | $725,887 | $198,915 |
| 2020 | 21 | 1,502 | 2,209 | $329,111 | $69,697 |
Total Patients
7,610
Total Services
9,106
Medicare Billing
$301,448
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 116 | 176 | $82,412 | $18,532 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 120 | $41,484 | $5,672 | 13.7% |
| 0004A | Adm sarscov2 30mcg/0.3ml bst | Office | 2022 | 114 | 114 | $15,960 | $4,097 | 25.7% |
| 0003A | Adm sarscov2 30mcg/0.3ml 3rd | Office | 2022 | 45 | 45 | $6,300 | $1,601 | 25.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 40 | 40 | $2,500 | $690.30 | 27.6% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2022 | 58 | 69 | $3,391 | $654.03 | 19.3% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 59 | 76 | $1,759 | $463.42 | 26.3% |
| 0002A | Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; second dose | Office | 2022 | 11 | 11 | $1,540 | $408.97 | 26.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $664.20 | $337.48 | 50.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 88 | 111 | $1,199 | $328.77 | 27.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 23 | 23 | $262.20 | $51.49 | 19.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 225 | 574 | $198,432 | $49,968 | 25.2% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 1,656 | 1,662 | $166,383 | $48,696 | 29.3% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 1,685 | 1,721 | $108,262 | $33,638 | 31.1% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 685 | 685 | $95,900 | $25,486 | 26.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 97 | 97 | $36,166 | $12,338 | 34.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 99 | 118 | $48,026 | $8,058 | 16.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 48 | 53 | $24,817 | $6,405 | 25.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 72 | 72 | $4,959 | $4,334 | 87.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 145 | 145 | $9,063 | $2,560 | 28.2% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 92 | 92 | $5,446 | $1,611 | 29.6% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2021 | 86 | 125 | $6,144 | $1,192 | 19.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 73 | 73 | $3,559 | $1,154 | 32.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 23 | 52 | $7,831 | $1,098 | 14.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2021 | 81 | 123 | $2,847 | $764.00 | 26.8% |
About Dr. Christopher Gonzaga, MD
Dr. Christopher Gonzaga, MD is a Infectious Disease healthcare provider based in Gallup, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538147640.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Gonzaga, MD has received a total of $723.87 in payments from pharmaceutical and medical device companies, with $52.96 received in 2024. These payments were reported across 24 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($723.87).
As a Medicare-enrolled provider, Gonzaga has provided services to 7,610 Medicare beneficiaries, totaling 9,106 services with total Medicare billing of $301,448. Data is available for 3 years (2020–2022), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Gallup, NM
- Active Since 01/09/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1538147640
Products in Payments
- ELAPRASE (Biological) $110.52
- TOUJEO (Drug) $105.25
- Xyrem (Drug) $102.69
- XARELTO (Drug) $60.22
- BEXSERO (Biological) $50.11
- ELIQUIS (Drug) $50.00
- Victoza (Drug) $23.83
- GVOKE HYPOPEN (Drug) $23.74
- ENTRESTO (Drug) $22.54
- SOLIQUA (Drug) $17.67
- Vascepa (Drug) $16.82
- SHINGRIX (Biological) $15.33
- LEQVIO (Drug) $15.15
- VPRIV (Biological) $13.83
- ASMANEX (Drug) $12.17
- LYRICA (Drug) $11.85
- JANUVIA (Drug) $10.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.